Pork ban in federal prisons draws scrutiny and requests
Edmond Ross of the Bureau of Prisons cites high pork costs and long declining inmate interest as reasons for removing pork from meals. Senator Grassley requests prisoner surveys, cost data, and economic evaluations, while the National Pork Producers Council explores options to counter the ban.
MENTIONED IN THIS ARTICLE
Edmond Ross
Prison Bureau
Ross
Grassley
Bureau of Prisons
National Pork Producers Council
Trade Association
Stephen Mally
the Gazette
Brenneman Park
Washington
Iowa
U.S
Charles Grassley
Federal Bureau of Prisons
Iran deal opposition stalls amid leadership turmoil and missile test
GOP critics in the House face a distracted schedule as Boehner's resignation sparks a leadership crisis. In the Senate, budget fights and debt limits loom while Iran conducts ballistic missile tests, fueling skepticism that the deal will be undone or strictly enforced. Senators Corker and Perdue lead a letter demanding a tougher response, arguing Iran will ignore international norms even after the deal.
MENTIONED IN THIS ARTICLE
House
John Boehner
Ohio
Senate
GOP
Congress
Iran
Senate Foreign Relations Committee
Bob
Corker
R-Tenn
Obama
U.N
White House
David Perdue
R-Ga
Hepatitis C drugs cost and use rise with new cures
Prescription data show 183000 hepatitis C drug fills January to June with Harvoni leading Medicare totals at 119033, a large share of total spending. Experts warn costs could ease as cures reach broader groups, while CMS notes uncertainty about future spending and patient access remains uneven.
MENTIONED IN THIS ARTICLE
Michael Kleinrock
IMS Institute For Healthcare Informatics
Kleinrock
Centers For Medicare and
Medicaid Services
Sean Cavanaugh
Medicare
CMS
Gilead Sciences
Wall Street
AbbVie
Sovaldi
Gilead
Cara Miller
Walid Gellad
Texas
Michelle Mynier
Liver Center
Harmeni
Mynier
Texas Department of Criminal Justice
Also Mentioned on This Page
Eral
Han
Deal
Reuters
Islamic Revolutionary Guard Corps’ Aerospace Force
The
University of Pittsburgh
Center For Pharmaceutical Policy